AR

Alex Rosen

Biotech Investor at Spruce Street Capital

New York, New York

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $3,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $6,500,000.00

Skills

Data Analysis
Clinical Research
Research
Statistics
Biotechnology
Strategy
Public Health
Lifesciences
Science
Program Evaluation
Molecular Biology
Life Sciences
Healthcare
Business Development
Leadership
Qualitative Research
Stata

Education

Work Experience

Spruce Street Capital LP

2024

  • Managing Partner

    2024

Upstream Bio

2023 - 2023

  • Board Member

    2023 - 2023

Venrock

2016 - 2023

  • Partner

    2020 - 2023

  • Biotech investor

    2016 - 2023

    Public and private/crossover biotechnology investing

RayzeBio

2022 - 2023

  • Board Member

    2022 - 2023

    IPO Sep 2023 (NASDAQ: RYZB) acquired by Bristol Myers Squibb for $4.1 billion, Dec 2023

Regeneron Pharmaceuticals, Inc.

2015 - 2015

  • Business Development

    2015 - 2015

McKinsey & Company

2014 - 2014

  • Summer Associate

    2014 - 2014